Related references
Note: Only part of the references are listed.Managing imatinib resistance in chronic myeloid leukaemia
Michael Osborn et al.
CURRENT OPINION IN HEMATOLOGY (2010)
Chemoprevention and Inhibition of P-glycoprotein in Cancer Cells by Chinese Medicinal Herbs
Helga Engi et al.
PHYTOTHERAPY RESEARCH (2008)
An update on overcoming MDR1-mediated multidrug resistance in cancer chemotherapy
K Takara et al.
CURRENT PHARMACEUTICAL DESIGN (2006)
Multidrug resistance: Retrospect and prospects in anti-cancer drug treatment
Ricardo Perez-Tomas
CURRENT MEDICINAL CHEMISTRY (2006)
EVE/cyclosporin (etoposide, vincristine, epirubicin with high-dose cyclosporin) - chemotherapy selected for multidrug resistance modulation
A Davidson et al.
EUROPEAN JOURNAL OF CANCER (2002)
Effects of 12 Ca2+ antagonists on multidrug resistance, MDR1-mediated transport and MDR1 mRNA expression
K Takara et al.
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES (2002)
Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification
ME Gorre et al.
SCIENCE (2001)
Efficacy and safety of a specific inhibitor of the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
BJ Druker et al.
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
